CBLL (CeriBell) FCF Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is CeriBell FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. CeriBell's Free Cash Flow for the three months ended in Dec. 2024 was $0.00 Mil. CeriBell's Revenue for the three months ended in Dec. 2024 was $18.53 Mil. Therefore, CeriBell's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, CeriBell's current FCF Yield % is -5.21%.

The historical rank and industry rank for CeriBell's FCF Margin % or its related term are showing as below:

CBLL' s FCF Margin % Range Over the Past 10 Years
Min: -125.45 Med: -66.65 Max: -55.59
Current: -101.83

During the past 3 years, the highest FCF Margin % of CeriBell was -55.59%. The lowest was -125.45%. And the median was -66.65%.

CBLL's FCF Margin % is ranked worse than
79.59% of 828 companies
in the Medical Devices & Instruments industry
Industry Median: -3.605 vs CBLL: -101.83

CeriBell FCF Margin % Historical Data

The historical data trend for CeriBell's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CeriBell FCF Margin % Chart

CeriBell Annual Data

Trend

Dec22

Dec23

Dec24

FCF Margin %

-125.45

-66.65

-55.59

CeriBell Quarterly Data
	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of CeriBell's FCF Margin %

For the Medical Devices subindustry, CeriBell's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CeriBell's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CeriBell's FCF Margin % distribution charts can be found below:

* The bar in red indicates where CeriBell's FCF Margin % falls into.

Save Embed

;

Save Embed

;

CeriBell FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

CeriBell's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-36.383	/	65.444
	=	-55.59 %

CeriBell's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	0	/	18.534
	=	0.00 %

CeriBell FCF Margin % Related Terms

Thank you for viewing the detailed overview of CeriBell's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

CeriBell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CeriBell Inc (NAS:CBLL) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085

Website

https://www.ceribell.com

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.